Synthesis, Spectroscopic Characterization, DFT Calculations, and Molecular Docking of Novel Thiourea Complexes and Their Cytotoxic and Antimicrobial Activities
Mahmoud M. Ahmed, Nour T. I. Salama, Samir Bondock, Amina A. Soayed, Rehab M. I. Elsamra
{"title":"Synthesis, Spectroscopic Characterization, DFT Calculations, and Molecular Docking of Novel Thiourea Complexes and Their Cytotoxic and Antimicrobial Activities","authors":"Mahmoud M. Ahmed, Nour T. I. Salama, Samir Bondock, Amina A. Soayed, Rehab M. I. Elsamra","doi":"10.1002/aoc.70125","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>This research presents the synthesis and comprehensive characterization of two novel bioactive thiourea derivatives (TU<sup>1</sup> and TU<sup>2</sup>) and their complexes with Pd(II), Cd(II), Cu(II), and Ni(II) salts. The ligands effectively formed stable chelates with the metal ions, displaying specific 1:1 and 1:2 stoichiometric ratios. Reduction of Cu(II) by thiourea was approved by the diamagnetic behavior of the yielded Cu(I)-TU complexes. Thermal analysis indicated that the complexes possess significant thermal stability. Computational studies provided detailed insights into the electronic properties, such as energy gaps and dipole moments, which correlate with the observed chemical reactivity and the cell membrane permeability to the complexes. Notably, the Cd(II)-TU<sup>2</sup> complex demonstrated significant in vitro anticancer activity with IC<sub>50</sub> values of 17.8 ± 0.6 μM and 12.0 ± 0.3 μM against MCF-7 and HepG-2 cell lines, respectively. This complex displayed slightly superior activity compared to cisplatin and nearly threefold the efficacy of imatinib. The superior activity of Cd(II)-TU<sup>2</sup> complex could be due to the existence of many electron-rich sites in the 1,4-benzodioxane moiety and less bulky acetamide substituent of TU<sup>2</sup> ligand. The data suggest that the synthesized compounds, especially the Cd(II)-TU<sup>2</sup> complex and the TU<sup>2</sup> ligand, are promising candidates for further investigation in therapeutic applications, particularly in the development of anticancer agents.</p>\n </div>","PeriodicalId":8344,"journal":{"name":"Applied Organometallic Chemistry","volume":"39 4","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Organometallic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/aoc.70125","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0
Abstract
This research presents the synthesis and comprehensive characterization of two novel bioactive thiourea derivatives (TU1 and TU2) and their complexes with Pd(II), Cd(II), Cu(II), and Ni(II) salts. The ligands effectively formed stable chelates with the metal ions, displaying specific 1:1 and 1:2 stoichiometric ratios. Reduction of Cu(II) by thiourea was approved by the diamagnetic behavior of the yielded Cu(I)-TU complexes. Thermal analysis indicated that the complexes possess significant thermal stability. Computational studies provided detailed insights into the electronic properties, such as energy gaps and dipole moments, which correlate with the observed chemical reactivity and the cell membrane permeability to the complexes. Notably, the Cd(II)-TU2 complex demonstrated significant in vitro anticancer activity with IC50 values of 17.8 ± 0.6 μM and 12.0 ± 0.3 μM against MCF-7 and HepG-2 cell lines, respectively. This complex displayed slightly superior activity compared to cisplatin and nearly threefold the efficacy of imatinib. The superior activity of Cd(II)-TU2 complex could be due to the existence of many electron-rich sites in the 1,4-benzodioxane moiety and less bulky acetamide substituent of TU2 ligand. The data suggest that the synthesized compounds, especially the Cd(II)-TU2 complex and the TU2 ligand, are promising candidates for further investigation in therapeutic applications, particularly in the development of anticancer agents.
期刊介绍:
All new compounds should be satisfactorily identified and proof of their structure given according to generally accepted standards. Structural reports, such as papers exclusively dealing with synthesis and characterization, analytical techniques, or X-ray diffraction studies of metal-organic or organometallic compounds will not be considered. The editors reserve the right to refuse without peer review any manuscript that does not comply with the aims and scope of the journal. Applied Organometallic Chemistry publishes Full Papers, Reviews, Mini Reviews and Communications of scientific research in all areas of organometallic and metal-organic chemistry involving main group metals, transition metals, lanthanides and actinides. All contributions should contain an explicit application of novel compounds, for instance in materials science, nano science, catalysis, chemical vapour deposition, metal-mediated organic synthesis, polymers, bio-organometallics, metallo-therapy, metallo-diagnostics and medicine. Reviews of books covering aspects of the fields of focus are also published.